MSc in Biopharmaceutical ManufacturingNow accepting applications for September 2021
Discipline: Analytical, Biopharmaceutical and Medical Science
Location: Galway - Dublin Road
NFQ Level: 9
Programme Duration: Eighteen Months
Mode of Study: Blended Learning
Application Route: Apply direct to GMIT
Entry Requirements: A H2.2 Bachelor degree at level 8 in a cognate science discipline such as biochemistry, microbiology, biology, chemistry, biomedical science/engineering or equivalent, is the minimum entry requirement for this programme.
The programme was designed in partnership with Irish companies manufacturing biopharmaceuticals and relevant industry stakeholders. Learners will develop both critical research skills in biopharmaceutical science and indepth understanding of the quality processes involved in the manufacture of biopharmaceuticals products.
The Masters programme will be delivered using a blended learning approach. Based on the input from industry, the programme design team have placed a strong emphasis on work-based learning and the year-long research project will be carried out in a company or within an applied research centre in GMIT.
The MSc in Biopharmaceutical Manufacturing will develop in-depth knowledge of biologics manufacturing and skills relevant to the biopharmaceutical sector through the delivery of a suite of modules, namely: Advanced Biopharmaceutical Science, Bioprocessing Technology, Immunology, Immunotherapeutics and Vaccine Technology, Biopharmaceutical Facilities, Machine Learning & Vision and Research project.
- Blended learning
- Project-based learning
- Team-Based Learning
- Self-Directed and Flexible Learning
- Industry speakers and Networking events
What to Expect
The programme has been designed for people in full-time employment in the Biopharmaceutical/Pharmaceutical sector. Lectures and tutorials will be delivered live on-line and will be recorded, available through GMIT’s learning platform Moodle. On-site activities are limited, but learners who take the elective module in Biopharmaceutical Science will be expected to be onsite for a 2 day on-site practical workshop in December.
The department will be running on-site medical technologies networking events and students enrolled on the Masters in Biopharmaceutical Manufacturing are welcome to attend.
Leaners are required to take a number of mandatory modules with a choice of one elective. Depending on the choice of elective this may be scheduled in either semester 1 or semester 2.
- Advanced Biopharmaceutical Science (10 ECTS)
- Bioprocessing Technology (5 ECTS)
- Design and Analysis of Experiments (5 ECTS)
- Biopharmaceutical Science (5 ECTS)
- Quality Management Systems and Regulatory Affairs (5 ECTS)
- Applied Immunology, Immunotherapeutics and Vaccine Technology (5 ECTS)
- Advanced Biopharmaceutical Science (10 ECTS) (Continued from semester 1)
- Six Sigma Management (5 ECTS)
- Validation for Biopharmaceuticals (5 ECTS)
- Applied research Project (55 ECTS)
- Biopharmaceutical Facilities (5 ECTS)
- Machine Learning Vision (5 ECTS)
- Applied research Project (55 ECTS) (Continued from semester 2)
The proposed Masters in Biopharmaceutical Science and Technology will equip graduates with a strong fundamental knowledge in high tech biopharmaceutical science. Data collated from the industry consultation expect graduates to fill roles in:
- Biotechnical production specialists
- Process Sciences Associates
- Process engineer
- Cell Line Engineers
- Cell Biology & Bioanalytical Analysts
- Data Science & Analytics Engineers
- Technical Operations Specialist
- Technical Services Specialist
- Validation Specialist
- Manufacturing Support Specialist
- Operations Lead/Manager
- QA Specialist/Manager
- Leadership roles in Research and Development
Graduates will be eligible to apply for progression to level 10 awards.
This is a full-time programme, and the Applied Research Project will be work-based and year-long. Those employed in the Biopharmaceutical/Pharmaceutical Sector can undertake projects with their employer, however the design of the project should be produced by the learner with the advice of the supervisors and must be of relevance to the programme. Students enrolled onto the programme who are not employed in the Biopharmaceutical/Pharmaceutical sector will be required to complete a year-long applied research project with a relevant industry or academic partner. This will be arranged by GMIT.
The closing date for receipt of applications is 15th September 2021.
The programme will commence on 27th September 2021.
How to Apply
Apply directly to GMIT using GMIT's Online Admissions system, selecting Application Type L9.
Please provide the following documentations to support your application:
1. A CV (max three pages) detailing their qualifications & career to date.
2. A personal motivational statement, which should include an outline of their plans and interests related to Biopharmaceutical/Pharmaceutical manufacturing.
English Language Requirements
English Language Requirements will be as determined by GMIT and as published in the Access, Transfer and Progression code.
Knowledge of the English language is considered as a basic requirement and non-native English speakers who are applicants for Level 9 taught programmes are required to have a minimum score of 6.0 in the IELTs or equivalent.
Contact for more information
Dr Eugene McCarthy
Head of Department of Analytical, Biopharmaceutical and Medical Sciences
School of Science and Computing